Loading viewer...
earnings
Format: PDF earnings
Gilead Sciences presents third quarter 2022 financial and operational results, including commercial performance across virology, oncology and other programs. The presentation discusses progress on key product candidates, clinical trial updates, and the impact of COVID-19 and Veklury on business operations.
earnings
59 Pages
earnings
10 Pages
Unknown
OGE Energy Q4 2016 Earnings Conference Call
earningsearnings
17 Pages
OGE Energy Corporation
Ambuja Cements Q1 FY25 Earnings Call July 2024
earningsearnings
17 Pages
Ambuja Cements Limited